Cargando…
International network of cancer genome projects
The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumors from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of over 25,000 cancer genomes at the genomic, epig...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902243/ https://www.ncbi.nlm.nih.gov/pubmed/20393554 http://dx.doi.org/10.1038/nature08987 |
_version_ | 1782183750877052928 |
---|---|
collection | PubMed |
description | The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumors from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of over 25,000 cancer genomes at the genomic, epigenomic, and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically-relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies. |
format | Text |
id | pubmed-2902243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
record_format | MEDLINE/PubMed |
spelling | pubmed-29022432010-10-15 International network of cancer genome projects Nature Article The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumors from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of over 25,000 cancer genomes at the genomic, epigenomic, and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically-relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies. 2010-04-15 /pmc/articles/PMC2902243/ /pubmed/20393554 http://dx.doi.org/10.1038/nature08987 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article International network of cancer genome projects |
title | International network of cancer genome projects |
title_full | International network of cancer genome projects |
title_fullStr | International network of cancer genome projects |
title_full_unstemmed | International network of cancer genome projects |
title_short | International network of cancer genome projects |
title_sort | international network of cancer genome projects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902243/ https://www.ncbi.nlm.nih.gov/pubmed/20393554 http://dx.doi.org/10.1038/nature08987 |
work_keys_str_mv | AT internationalnetworkofcancergenomeprojects |